Abstract 092 Table
Appropriate therapy (shock or ATP)Inappropriate shockNo therapyNo follow-up
Secondary prevention: NICE + ESC criteria (n  =  104)50 (48%)5 (4.8%)48 (46%)1
Primary prevention: NICE + ESC criteria (n  =  78)17 (22%)060 (77%)1
Primary prevention: ESC criteria only (n  =  39)10 (26%)3 (7.7%)25 (64%)1
Primary prevention total (n  =  117)27 (23%)3 (2.6%)85 (73%)2
Total (n  =  221)7781333
  • ATP, anti-tachycardia pacing; ESC, European Society of Cardiology; NICE, National Institute for Health and Clinical Excellence.